MIBK (Methyl Isobutyl Ketone) is an aliphatic ketone that functions as both a denaturant and solvent in cosmetic products. Current use in cosmetic products is very limited, but MIBK is reported to be used in one nail correction pen (volume = 3 ml) at a concentration of 21 %. The maximum percutaneous absorption rate in guinea pigs is 1.1 /xmol/min/cm2 at 10 to 45 min. Metabolites include 4-hydroxy-4-methyl-2-pentanone (oxidation product) and 4-methyl-2-pentanol (4-MPOL) (reduction product). Values for the serum half-life and total clearance time of MIBK in animals were 66 min and 6 h, respectively. In clinical tests, most of the absorbed MIBK had been eliminated from the body 90 min post exposure. MIBK was not toxic via the oral or dermal route of exposure in acute, short-term, or subchronic animal studies, except that nephrotoxicity was observed in rats dosed with 1 g/kg in a short-term study. MIBK was an ocular and skin irritant in animal tests. Ocular irritation was noted in 12 volunteers exposed to 200 ppm MIBK for 15 min in a clinical test. A depression of the vestibulo-oculomotor reflex was seen with intravenous infusion of MIBK (in an emulsion) at 30 μ/kg/min in female rats. The no-observed-effect level in rats exposed orally to MIBK was 50 mg/kg. Both gross and microscopic evidence of lung damage were reported in acute inhalation toxicity studies in animals. Short-term and subchronic inhalation exposures (as low as 100 ppm) produced effects in the kidney and liver that were species and sex dependent. Dermal doses of 300 or 600 mg/kg for 4 months in rats produced reduced mitotic activity in hair follicles, increased thickness of horny and granular cell layers of the epidermis, a decrease in the number of reactive centers in follicles (spleen), an increase in the number of iron-containing pigments in the area of the red pulp (spleen), and a reduction in the lipid content of the cortical layer of the adrenal glands. Neuropathological changes in the most distal portions of the tibial and ulnar nerves were observed in young adult rats which inhaled 1500 ppm MIBK for up to 5 months. No adverse effects were seen in any other neurological end point by any route of exposure in other studies using rats or other animal species. Clinical tests demonstrated a threshold for MIBK-induced irritation of the lungs at 0.03 to 0.1 mg/L after 1 min of respiration. MIBK was not mutagenic in the Ames test or in a mitotic gene-conversion assay in bacteria. Mammalian mutagenicity test results were also negative in the following assays: mouse lymphoma, unscheduled DNA synthesis, micronucleus, cell transformation, and chromosome damage. MIBK did not induce any treatment-related increases in embryotoxicity or fetal malformations in pregnant Fischer 344 rats or CD-I mice that inhaled MIBK at concentrations of 300,1000, or 3000 ppm. There was evidence of treatment-related maternal toxicity only at the highest concentration tested. MIBK applied to the tail of rats daily at doses of 300 or 600 mg/kg for 4 months produced changes in the testes, including a reduction in the number of spermatocytes, spermatids, and spermatozoa. An ongoing carcinogenicity study of MIBK being conducted by the National Toxicology Program will be considered when the results are available. On the basis of the information that is currently available, MIBK is considered safe as used in nail polish removers and as an alcohol denaturant in cosmetic products.
References
1.
Alarie, Y.1966.Irritating properties of airborne materials to the upper respiratory tract.Arch. Environ. Health13, 433–449.
2.
Alden, C. L.1986.A review of unique male rat hydrocarbon nephropathy.Toxicol Pathol.14, 109–111.
3.
Alden, C. L., R. L. Kenerva, G. Ridder, and L. C. Stone1984.The pathogenesis of the nephrotoxicity of volatile hydrocarbons in the male rat. In Renal effects of petroleum hydrocarbons, ed. M. A. Mehlman, G. P. Hemstreet, J. J. Thorpe, and N. K. Weaver, 107–120. Princeton: Princeton Sei.
4.
American Conference of Governmental Industrial Hygienists (ACGIH). 2000. 2000 TLVs and BEIs based on the documentations of the threshold limit values for chemical substances and physical agents and biological exposure indices. Cincinnati: ACGIH, 49.
5.
Batyrova, T. F.1973.Substantiation of the maximum allowable concentration of methyl isobutyl ketone in the air of a workplace (translated).Gig. Tr. Pro. Zabol.17, 52–53.
6.
Bellanca, J. A., P. L. DavisL, B. Donnelly, L. A. Dal Cortivo, and S. B. Weinberg1982.Detection and quantitation of multiple volatile compounds in tissues by GC and GC/MS.J. Anal. Toxicol6, 238–240.
7.
Billmaier, D., H. T. Yee, N. Allen, B. Craft, N. Williams, S. Epstein, and R. Fontaine1974.Peripheral neuropathy in a coated fabrics plant.J. Occup. Med.16, 665–671.
8.
Brondeau, M. T., M. Ban, P. Bonnet, J. P. Guenier, and J. de Ceaurriz1989.Acetone compared to other ketones in modifying the hepatotoxicity of inhaled 1,2-dichlorobenzene in rats and mice.Toxicol Lett.49, 69–78.
9.
Brooks, T. M., A. L. Meyer, and D. H. Hutson1988.The genetic toxicology of some hydrocarbon and oxygenated solvents.Mutagenesis3, 227–232.
10.
Brooks, T. M., and B. J. Dean1981.Mutagenic activity of 42 coded compounds in the Salmonella/mammalian assay with pre-incubation. In Evaluation of short-term tests for carcinogens, éd. F. J. de Serres and J. Ashby, 261–270. New York: Elsevier.
11.
Budavari, S. ed, 1989. Isopropylacetone entry. The Merck Index, 11th ed.Rahway, NJ: Merck & Co.
12.
Bushy Run Research Center. 1982. Initial submission: Nine-day inhalation study of methyl isobutyl ketone in rats and mice with cover letter dated 7/29/92. NTIS Report No. OTS0537577.
13.
Carnegie Mellon Institute of Research. 1983. Comparative pathology on rats given methoxyacetone and five other aliphatic ketones in drinking water (Ketone neurotoxicity). NTIS Report No. OTS0206068.
14.
Chemical Manufacturers Association (CMA). 1981. Information on ketones from ChemicalManufacturers Association. NTIS Report No. OTS0512076.
15.
Clive, D., and J. F. S. Spector1975.Laboratory procedure for assessing specific locus mutations at the TK locus in cultured L51784 mouse lymphoma cells.Mutat. Res,31, 17–29.
16.
Clive, D., K. O. Johnson, J. F. S. Spector, A. G. Batson, and M. M. M. Brown1979.Validation and characterization of L51784/TK+/- mouse lymphoma mutagen assay system.Mutat. Res.59, 61–108.
17.
CMA. 1999a. Comments on CIR Review. Impurities. Unpublished data submitted by the Chemical Manufacturers Association. December 1999 (4 pages).
18.
CMA. 1999b. SIDS initial asssessment profile. Methyl isobutyl ketone (MIBK). Unpublished data submitted by CMA, December 21, 1999 (21 pages).
19.
Clair, R., M. Tua, and H. Simian1991.Capillary columns in series for GC analysis of volatile organic pollutants in atmospheric and alveolar air.J. High. Resolut. Chromatog.14, 383–391.
20.
Cobb, G. R., and R. S. Braman1991.Determination of multiple atmospheric diffusion coefficients using the carbon hollow tube gas chromatography method.J. Air Waste Mgmt. Assoc.41, 967–971.
21.
Cometto-Muniz, J. E., and W. S. Cain1991.Influence of airborne contaminants on olfaction and the common chemical sense. In Smell and taste in health and disease, ed. T. V. Getchell et al., 765–786. New York: Raven Press.
22.
Committee of Revision of the United States Pharmacopeial Convention. 2000. The National Formulary, 19th ed., 2404,2479. Rockville, MD: United States Pharmacopeial Convention, Inc.
23.
Cosmetic, Toiletry, and Fragrance Association (CTFA). 2000. MIBK concentration of use. Unpublished data submitted by CTFA (1 page).
24.
Cunningham, J., M. Sharkawi, and G. L. Plaa1989.Pharmacological and metabolic interactions between ethanol and methyl n-butyl ketone, methyl isobutyl ketone, methyl ethyl ketone, or acetone in mice.Fundam. Appl. Toxicol.13, 102–109.
25.
Dahlstrom-King, L., P. D. Souich, J. Couture, and G. L. Plaa1990.The influence of severity of bile flow reduction, cycloheximide, and methyl isobutyl ketone pretreatment on the kinetics of taurolithocholic acid disposition in the rat.Toxicol. Appl. Pharmacol.104, 312–321.
26.
David, R. M., L. G. Bernard, M. I. Banton, T. R. Tyler, D. C. Topping, M. W. Gill, and J. L. O'Donoghue, 1999.The effect of repeated methyl isobutyl ketone vapor exposure on schedule-controlled opérant behavior in rats.Neurotoxicology20, 583–594.
27.
De Ceaurriz, J., J. C. Micillino, P. Bonnet, and J. P. Guenier1981.Sensory irritation caused by various industrial airborne chemicals.Toxicol. Lett.9, 137–143.
28.
De Ceaurriz, J., J. C. Micillino, B. Marignac, P. Bonnet, J. Müller, and J. P. Guenier1984.Quantitative evaluation of sensory irritating and neurobehavioral properties of aliphatic ketones in mice.Food Chem. Toxicol.22, 545–550.
29.
Dick, R., D. Dankovic, J. Setzer, F. Phipps, and L. Lowry1990.Body burden profiles of methyl ethyl ketone and methyl isobutyl ketone exposure in human subjects.Toxicologist10:112.
30.
Dick, R. B., E. F. Krieg, Jr., J. Setzer, and B. Taylor1992.Neurobehavioral effects from acute exposures to methyl isobutyl ketone and methyl ethyl ketone.Fundam. Appl. Toxicol.19, 453–473.
31.
DiVincenzo, G. D., M. L. Hamilton, C. J. Kaplan, and J. Dedinas1980.Characterization of the metabolites of methyl-n-butyl ketone. In Experimental and clincal neurotoxicology, ed. P. S. Spencer and H. H. Schaumburg, 846–855. Baltimore: Willaims and Wilkins.
32.
Divincenzo, G. D., C. J. Kaplan, and J. Dedinas1976.Characterization of the metabolites of methyl n-butylketone, methyl iso-butyl ketone andmethyl ethyl ketone in guinea pig serum and their clearance.Toxicol. Appl. Pharmacol.36, 511–522.
33.
Divincenzo, G. D., and W. J. Krasavage1974.Serum ornithine carbamyl trans-ferase as a liver response test for exposure to organic solvents.Am. Ind. Assoc. J.35, 21–29.
34.
Dowty, B. J., J. L. Laseter, and J. Storer1976.Transplacental migration and accumulation in blood of volatile organic constituents.Pédiatrie Res.10, 696–701.
35.
Duguay, A. B., and G. L. Plaa1993.Plasma concentrations in methyl isobutyl ketone-potentiated experimental cholestasis after inhalation or oral administration.Fundam. Appl. Toxicol.21, 222–227.
36.
Duguay, A. B., and G. L. Plaa1995.Tissue concentrations of methyl isobutyl ketone, methyl n-butyl ketone and their metabolites after oral or inhalation exposure.Toxicol. Lett.75, 51–58.
37.
Duguay, A. B., and G. L. Plaa1997.Ketone potentiation of intrahepatic cholestasis: Effect of two aliphatic isomers.J. Toxicol. Environ. Health50, 41–52.
38.
Eastman Kodak Company. 1977. Chronic intraperitoneal administration of MnBK, MEK, MiBK, and combinations of these to rats. NTIS Report No. OTS0206514.
39.
Eastman Kodak Company. 1982a. Acute intraperitoneal toxicity of methyl ethyl ketone, methyl n-butyl ketone, and methyl iso-butyl ketone to rats and guinea pigs. NTIS Report No. OTS0206515.
40.
Eastman Kodak Company. 1982b. Electromyographic examination of dogs treated with ketone solvents. NTIS Report No. OTS0206515.
41.
Eastman Kodak Company. 1992. Initial submission: Letterfrom Eastman Kodak Company to USEPA regarding toxicity studies of 2-hexanone and metabolites with cover letter dated 9/28/92. Neurotoxicity studies on methyl n-butyl ketone (Ace. No. 901958), methyl isobutyl ketone (Ace. No. 900416), methyl ethyl ketone (Ace. No. 900383), and their combinations (this neurotoxicity study dated 1981). NTIS Report No. OTS0555051.
42.
Eastman Kodak Company. 1996. Methyl isobutyl ketone. A thirteen-week inhalation schedule-controlled opérant behavior study in the rat. Health and Environmental Laboratories (HAEL) No. 95-0300. (Submitted by FDA in response to an FOI request-1998; 686 pages.)
43.
Elkins, H. B., ed 1959.Chemistry of industrial toxicology, 121. New York: John Wiley and Sons.
44.
Environmental Protection Agency (EPA). 1973. Current practice in GC-MS analysis of organics in water. NTIS Report No. PB 224 947/2.
EPA. 1979. Fourth report of the Interagency Testing Committee; Receipt of the report and request for comments. Federal Register 44:31866-31888.
47.
EPA. 1991. Alpha 2u-globulin: Association with chemically induced renal toxicity and neoplasia in the male rat. NTIS Report No. PB92-143668.
48.
European Chemical Industry Ecology and Toxicology Centre (ECETOC). 1987. Joint assessment of commodity chemicals. No. 8. Brussels: ECETOC, 1-29.
49.
European Economic Community (EEC). 1999. EEC Cosmetics Directive 76/768/EEC, as amended, Annexes I through VII. Brussels :EEC.
50.
Exxon Chemical Company. 1982. The aspiration hazard and toxicity of a series of ketones. NTIS Report No. OTS0206264.
51.
Fernandes, M.1985.Methodology for the analysis of volatile compounds in food packaging materials.Coletanea. Inst. Technol. Ailment15, 49–59.
52.
Food and Drag Administration (FDA). 1998. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
53.
Gagnon, P., D. Mergler, and S. Lapare1994.Olfactory adaptation, threshold shift and recovery at low levels of exposure to methyl isobutyl ketone (MIBK).Neurotoxicology15, 637–642.
54.
Available from the Director, Cosmetic Ingredient Review, 1101 17th Street, NW, Suite 310, Washington, DC 20036, USA.
55.
Gautheron, P., J. Giroux, M. Cottin, et al 1994.Interlaboratory assessment of the bovine corneal opacity and permeability (BCOP) assay.Toxicol. In Vitro8, 381–392.
56.
Geller, I., E. Gause, H. Kaplan, and R. J. Hartmann1979.Effects of acetone, methyl ethyl ketone, and methyl isobutyl ketone on a match-to-sample task in the baboon.Pharmacol. Biochem. Behav.11:401–406.
57.
Geller, I., J. R. Rowlands, and H. L. Kaplan1978.Effects of ketones on opérant behavior of laboratory animals. In Voluntary inhalation of industrial solvents, 363. Washington, DC: US Department of Health, Education, and Welfare. DHEW Publication No. 79-779.
58.
Goodyear Tire & Rubber Company. 1982. Mutagenicity evaluation of methyl isobutyl ketone (MIBK) with cover letter. NTIS Report No. OTS0205942.
59.
Granvil, C. P., M. Sharkawi, and G. L. Plaa1994.Metabolic fate of methyl n-butyl ketone, methyl isobutyl ketone, and their metabolites in mice.Toxicol. Lett.70, 263–267.
Grober, E., and H. H. Schaumburg2000.Occupational exposure to methyl isobutyl ketone causes lasting impairment in working memory.Neurology54, 1853–1855.
62.
Haworth, S., T. Lawlor, K. Mortelmans, W. Speck, and E. Zeiger1983.Salmonellamutagenicity test results for 250 chemicals. Environ. Mutat. Suppl. 1:3–142.
63.
Hazleton Labs, Inc. 1982. Human sensory irritation-Thresholds five ketones. Final Report. NTIS Report No. OTS0206265.
64.
Hazleton Labs, Inc. 1992. Assessment and comparison of subacute inhalation toxicities of three ketones. NTIS Report No. OTS0206267.
65.
Hjelm, E. W., A. Boman, P. Fernstrom, M. Hagberg, and G. Johanson1991.Percutaneous uptake and kinetics of methyl isobutyl ketone (MIBK) in the guinea pig.Toxicol. Lett.56, 79–86.
66.
Hjelm, E. W., M. Hagberg, A. Iregren, and A. Lof1990.Exposure to methyl isobutyl ketone: Toxicokinetics and occurrence of irritative and CNS symptoms in man.Int. Arch. Occup. Environ. Health62, 19–26.
67.
Iregren, A., M. Tesarz, and E. Wigaeus-Hjelm, 1993.Human experimental MIBK exposure effects on heart rate performance and symptoms.Environ. Res.63, 101–108.
68.
Joseph, L.-D., I. M. Yousef, G. L. Plaa, and M. Sharkawi1992.Potentiation of lithocholic-acid-induced cholestasis by methyl isobutyl ketone.Toxicol. Lett.61, 39–47.
69.
Kennah, H. E., S. Hignet, P. E. Laux, J. D. Dorko, and C. S. Barrow1989.An objective procedure for quantitating eye irritation based upon changes of corneal thickness.Fundam. Appl. Toxicol.12, 258–268.
70.
Krishnan, K., J. Brodeur, G. L. Plaa, and M. Charbonneau1992.Modulation of hexachlorobenzene-induced hepatic porphyria by methyl isobutyl ketone in the rat.Toxicol. Lett.61, 167–174.
71.
Lande, S. S., P. R. Durkin, D. H. Christopher, P. H. Howard, and J. Saxena. 1976. Investigation of selected potential environmental contaminants. Ketonic solvents. NTIS Report No. PB252970.
72.
Lam, C.-W, T. J. Galen, J. F Boyd, and D. L. Pierson1990.Mechanism of transport and distribution of organic solvents in blood.Toxicol. Appl. Pharmacol.104, 117–129.
73.
Lapin, E. P., S. Weissbarth, H. S. Maker, and G. M. Lehrer1982.The sensitivities of creatine and adenylate kinases to the neurotoxins acrylamide and methyl n-butyl ketone.Environ. Res.28, 21–31.
74.
Lewis, R. J., ed 2000.Sax's dangerous properties of industrial materials, 10th ed., vol. 3, 1962. New York: John Wiley & Sons.
75.
Litton Bionetics, Inc. 1977. Final report. Mutagenicity plate assay on methyl isobutyl ketone. NTIS Report No. OTS0206124.
76.
Litton Bionetics Inc. 1991. Letter concerning the enclosed Ames Salmonella/microsome plate tests on methyl ethyl ketone and methyl isobutyl ketone with attachments. NTIS Report No. OTS0534320.
77.
Mackay, D., and A. W Wolkoff1973.Rate of evaporation of low solubility contaminants from water bodies to atmosphere.Environ. Sei. Technol.7:611–614.
78.
Malyscheva, M. V.1988.Effect on toxicity of the manner in which methylisobutylketone penetrates the skin (translated).Gig. Sanit.10, 79–80.
79.
McOmie, W A., and H. H. Anderson1949.Comparative toxicologie effects of some isobutyl carbinols and ketones, vol. 2, 217–230. Berkeley, CA: University of California, Berkeley.
80.
Moshlakova, L. A., and T. V. Indina1986.Gas Chromatographie determination of ketones present simultaneously in the air of the work area and in the washings from workers' skin (translated).Gig. Sanit.2, 90–91.
81.
Nagano, M., K. Harada, J. Misumi, and S. Nomura1988.Effects of methyl isobutyl ketone on methyl n-butyl ketone neurotoxicity in rats.Jpn. J. Ind. Health.30, 50–51.
82.
National Institute of Occupational Safety and Health (NIOSH). 1978. Criteria for a recommended standard. Occupational exposure to ketones. NTIS Report No. PB80-176076.
83.
National Toxicology Program (NTP). 1999. Management status report produced from NTP chemtrack system. Research Triangle Park, NC: NTP.
84.
O'Donoghue, J. L., S. R. Haworth, R. D. Curren, et al 1988.Mutagenicity studies on ketone solvents methyl ethyl ketone, methyl isobutyl ketone, and isophorone.Mutat. Res.206, 149–162.
85.
Panson, R. D., and C. L. Winek1980.Aspiration toxicity of ketones.Clin. Toxicol.17, 271–318.
86.
Phillips, R. D., E. J. Moran, D. E. Dodd, E. H. Fowler, C. D. Kary, and J. O'Donoghue, 1987.A 14-week vapor inhalation toxicity study of methylisobutylketone.Fundam. Appl. Toxicol.9, 380–388.
87.
Pilon, D., J. Brodeur, and G. L. Plaa1988.Potentiation of carbon tetrachloride-induced liver injury by ketonic and ketogenic compounds. Role of the carbon tetrachloride dose.Toxicol. Appl. Pharmacol.94, 183–190.
88.
Plaa, G. L., and P. Ayotte1985.Taurolithocholate-induced intrahepatic cholestasis potentiation by methylisobutylketone and methyl-n-butylketone in rats.Toxicol. Appl. Pharmacol.80, 228–234.
89.
Raccio, J. M., and J. R. Widomski1981.Quality control of flavors in soft drinks and the analysis of residual solvents in food packaging films utilizing headspace sampling with open tubular columns.Chromatog. Newsletter9, 42–45.
90.
Raymond, P., and G. L. Plaa1995a.Ketone potentiation of haloalkane-induced hepato and nephrotoxicity. II. Implication of monooxygenases.J. Toxicol. Environ. Health46, 317–328.
91.
Raymond, P., and G. L. Plaa1995b.Ketone potentiation of haloalkane-induced hepato- and nephrotoxicity. I. Dose-response relationships.J. Toxicol. Environ. Health45, 465–480.
92.
Santucci, L. G., ed 1999.List of Japanese cosmetic ingredients, 4th ed., 76. Washington, DC: CTFA.
93.
Sato, A., and T. Nakajima1979.Partition coefficients of some aromatic hydrocarbons and ketones in water, blood, and oil.Br. J. Ind. Med.36, 231–234.
94.
Sato, A., and T. Nakajima1987.Pharmacokinetics of organic solvent vapors in relation to their toxicity.Scand. J. Work Environ. Health13, 81–93.
95.
Selkoe, D. J., L. Luckenbill-Edds, and M. L. Shelanski1978.Effects of neu-rotoxic industrial solvents on cultured neuroblastoma cells: Methyl n-butyl ketone, n-hexane and derivatives.J. Neuropathol. Exp. Neurology37, 768–789.
96.
Sharkawi, M., C. Granvil, A. Faci, and G. L. Plaa1994.Pharmacodynamic and metabolic interactions between ethanol and two industrial solvents (methyl n-butyl ketone and methyl isobutyl ketone) and their principal metabolites in mice.Toxicology94, 187–195.
97.
Shell Chemical Corporation. 1983. Toxicity data sheet. Methyl isobutyl ketone. NTIS Report No. OTS0205872.
98.
Silverman, L., H. F. Schulte, and M. W. First1946.Further studies on sensory response to certain industrial solvent vapors.J. Ind. Hyg. Toxicol.28, 262–266.
99.
Smyth, H. F., C. P. Carpenter, and C. S. Weil1951.Range-finding toxicity data: List IV.Arch. Ind. Hyg. Occup. Med.4, 119–122.
100.
Specht, H.1938.Acute response of guinea pigs to inhalation of methyl isobutyl ketone.Public Health Reports53, 292–300.
101.
Specht, H., J. W Miller, P. J. Valaer, and R. R Sayers1940.Acute response of guinea pigs to the inhalation of ketone vapors (NIH Bulletin No. 176). Washington, DC: US Public Health Service, Division of Industrial Hygiene.
102.
Spencer, P. S., and H. H. Schaumburg1976.Feline nervous system response to chronic intoxication with commercial grades of methyl n-butyl ketone, methyl isobutyl ketone, and methyl ethyl ketone.Toxicol. Appl. Pharmacol.37, 301–311.
103.
Spencer, P. S., H. H. Schaumburg, R. L. Raleigh, and C. J. Terhaar1975.Nervous system degeneration produced by the industrial solvent methyl n-butyl ketone.Arch. Neurol.32, 219–222.
104.
Tanii, H., H. Tsuji, and K. Hashimoto1986.Stracture-toxicity relationship of monoketones.Toxicol. Lett.30, 13–18.
105.
Tham, R., I. Bunnfors, B. Eriksson, B. Larsby, S. Lindgren, and L. M. Odkvist1984.Vestibulo-Ocular disturbances in rats exposed to organic solvents.Acta Pharmacol. Toxicol.54, 58–63.
106.
Tyl, R. W., K. A. France, L. C. Fisher, M. Pritts, and T. R. Tyler1987.Developmental toxicity evaluation of inhaled methylisobutylketone in Fischer 344 rats and CD-I mice.Fundam. Appl. Toxicol.8, 310–327.
107.
Union Carbide Corporation. 1983. Methyl isobutyl ketone vapor ninety-day inhalation study on rats pathology report with cover letter to CMA dated 061583. NTIS Report No. OTS0507467.
108.
van Joost, T. H., M. Schulten-Lukassen, E. Stolz, A. F. D. Smit, and P. H. Ribbens1984.Occupational contact dermatitis to mesylisopropy llaceate.Contact Dermatitis10, 187–188.
109.
Verschueren, K., ed 1983.Handbook of environmental data on organic chemicals, 2nd ed., 459–461. New York: Van Nostrand Reinhold.
110.
Vézina, M., P. Ayotte, and G. L. Plaa1985.Potentiation of necrogenic and cholestatic liver injury by 4-methyl-2-pentanone.Can. Fed. Biol. Soc.28:221.
111.
Vézina, M., A. B. Kobusch, P. Du Souich, E. Greselin, and G. L. Plaa1990.Potentiation of chloroform-induced hepatotoxicity by methyl isobutyl ketone and two metabolites.Can. J. Physiol. Pharmacol.68, 1055–1061.
112.
Vézina, M., and G. L. Plaa1987.Potentiation by methyl isobutyl ketone of the cholestasis induced in rats by a manganese-bilirabin combination or manganese alone.Toxicol. Appl. Pharmacol.91, 477–483.
113.
Vézina, M., and G. L. Plaa1988.Methyl isobutyl ketone metabolites and potentiation of the cholestasis induced in rats by amanganese-bilirabin combination or manganese alone.Toxicol. Appl. Pharmacol.92, 419–427.
114.
Weiler, J. P., and M. Wolf1989.Mass spectroscopy and headspace gas chro-matography.Beitr. gerichtl. Med.47, 525–532.
115.
Wenninger, J. A., R. C. Canterbery, and G. N. McEwen, Jr., eds 2000.International cosmetic ingredient dictionary and handbook, 8th ed., vol L., 859. Washington, DC: CTFA.
116.
Williams, G. M.1977.Carcinogen-induced DNA repair in primary rat liver cell cultures, a possible screen for chemical-carcinogens.Cancer Lett.1:231–237.
117.
William, G. M.1979.The detection of chemical mutagens/carcinogens by DNA repair and mutagenesis in liver cultures. In Chemical mutagens, éd. F. J. de Serres and A. Hollaender, 71–79. New York: Plenum.
118.
World Health Organization (WHO). 1990. Environmental health criteria for methyl isobutyl ketone. Environ Health Criter. 117:1-79.
119.
Wright-Patterson Air Force Base Aerospace Medical Research Laboratory. 1971. Effect of 90-day continuous exposure to methylisobutylketone on dogs, monkeys and rats. NTIS Report No. AD730291.
120.
Zakhari, S., P. Levy, M. Liebowitz, and D. M. Aviado1977.Acute oral, in-traperitoneal, and inhalation toxicity of methyl isobutyl ketone in the mouse. In Isopropanol and ketones in the environment, ed. L. Goldberg, 93–133. Cleveland: CRC Press.
121.
Zeiger, E., B. Anderson, S. Haworth, T. Lawlor, and K. Mortelmans1992.Salmonella mutagenicity tests. V. Results from the testing of 311 chemicals.Environ. Mol. Mutagen.21, 2–141.
122.
Zimmermann, F K., I. Scheel, and M. A. Resnick1989.Induction of chromosome loss by mixtures of organic solvents including neurotoxins.Mutat. Res.224, 287–304.
123.
Zlatkis, A., and H. M. Liebich1971.Profile of volatile metabolites in human urine.Clin. Chem.17, 592–594.
